Yongzhong Cheng
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A microenvironment-adaptive bilayer composite dressing for disrupting MRSA biofilms and promoting wound regeneration via ROS-mediated immune regulation.
Journal: Bioactive materials
Published: March 10, 2026
Unfolding the policy dynamics of medical data assetization in Chinese public healthcare institutions: evidence from Latent Dirichlet Allocation and dynamic topic modeling analysis.
Journal: Frontiers in public health
Published: February 06, 2026
Integrating PROTAC-based targeted protein degradation with nanodelivery systems to overcome cancer therapeutic resistance.
Journal: Advanced drug delivery reviews
Published: October 10, 2025
Biomimetic Ru-Mn Nanozyme with Cascade Catalytic Activity Attenuates Secondary Brain Injury in Intracerebral Hemorrhage.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 30, 2025
Global trends in the burden of alcohol use disorders in the working-age population from 1990 to 2021 and projections for the next 20 years.
Journal: Frontiers in public health
Published: April 25, 2025
Two-Way Referrals in Chinese Medical Consortia Under the Framework of Hierarchical Diagnosis and Treatment: Progress and Challenges.
Journal: Journal of evidence-based medicine
Published: March 04, 2025
A Glutathione-Responsive System with Prodrug and Sensitization Strategies for Targeted Therapy of Glioma.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: February 08, 2025
Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform.
Journal: Signal transduction and targeted therapy
Published: February 01, 2025
Sharp injuries to blood-borne pathogens among healthcare workers and influencing factors in a tertiary specialist hospital (2019-2022): a retrospective study.
Journal: Scientific reports
Published: October 09, 2024
BRD4 Degradation Enhanced Glioma Sensitivity to Temozolomide by Regulating Notch1 via Glu-Modified GSH-Responsive Nanoparticles.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 19, 2024
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.
Journal: Signal transduction and targeted therapy
Published: January 07, 2024
Last Updated: 09/26/2026